Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
AT&T Shares Drop to 30-Year Low
Shares of AT&T hit a 30-year low after reports showed thousands of lead-covered cables in several locations across the country. The Wall Street Journal reported on the story earlier in July.
Load More